S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer
Status:
Withdrawn
Trial end date:
2003-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells. It is not
yet known whether cisplatin is more effective when combined with paclitaxel or gemcitabine in
treating cervical cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of cisplatin combined with
paclitaxel to that of cisplatin combined with gemcitabine in treating women who have
recurrent, persistent, or metastatic cervical cancer.